Patients with PI3K pathway alterations (red curve) exhibited a notable decline in survival probability compared to those without alterations (blue curve), suggesting that PI3K dysregulation may contribute to disease progression and worse prognosis in NHW HCC. The gene discussed is PIK3CB; the disease is hepatocellular carcinoma.